KLAS ranks infection control vendors
CareFusion's MedMined scored highest in overall performance for infection control vendors ranked in a KLAS report.
CareFusion maintained a similar score compared to its last evaluation, earning an overall performance score of 88.4 this year, according to the Orem, Utah-based research firm. Improving their scores this year were Hospira Infection Control Assist (TheraDoc) with a score of 86.6 and Premier SafetySurveillor with a score of 78.5. Those two firms were ranked second and third in the report, respectively.
KLAS noted that with recent actions by CMS, such as “its refusal to pay for treatment associated with hospital acquired infections and more extensive reporting requirements,” providers are seeking out accurate and efficient ways to monitor infections. The KLAS report, titled “Infection Control 2011: Better Tools + More Data = Less Infection?” is based on interviews with more than 200 providers, including 274 infection preventionists (IPs).
“Surveillance systems serve as an essential tool to arm IPs with useful, actionable data early and often,” said report author Steve VanWagenen, KLAS research director. “The IPs take the data to the hospital floor and then help clinicians make necessary changes. If the right changes can be made at the clinician level, infection rates decrease, and so do the costs associated with infections.”
According to the firm, the report examines vendors that provide the most effective infection control and surveillance systems currently available, as well as 10 vendors that are entering the market. Also included is information about what hospitals should take into account when looking for a surveillance system, including basic functionality, vendor service model, incentives offered and reporting capabilities.
“There is plenty of room for growth in this market, said VanWagenen. “Even with a steady increase in adoption over the past two years, KLAS estimates that only 20 to 25 percent of hospitals currently have a real-time infection surveillance system, which is up from 10 to 15 percent in 2009, but still significantly low overall.”
For more information or to purchase the report, click here.
CareFusion maintained a similar score compared to its last evaluation, earning an overall performance score of 88.4 this year, according to the Orem, Utah-based research firm. Improving their scores this year were Hospira Infection Control Assist (TheraDoc) with a score of 86.6 and Premier SafetySurveillor with a score of 78.5. Those two firms were ranked second and third in the report, respectively.
KLAS noted that with recent actions by CMS, such as “its refusal to pay for treatment associated with hospital acquired infections and more extensive reporting requirements,” providers are seeking out accurate and efficient ways to monitor infections. The KLAS report, titled “Infection Control 2011: Better Tools + More Data = Less Infection?” is based on interviews with more than 200 providers, including 274 infection preventionists (IPs).
“Surveillance systems serve as an essential tool to arm IPs with useful, actionable data early and often,” said report author Steve VanWagenen, KLAS research director. “The IPs take the data to the hospital floor and then help clinicians make necessary changes. If the right changes can be made at the clinician level, infection rates decrease, and so do the costs associated with infections.”
According to the firm, the report examines vendors that provide the most effective infection control and surveillance systems currently available, as well as 10 vendors that are entering the market. Also included is information about what hospitals should take into account when looking for a surveillance system, including basic functionality, vendor service model, incentives offered and reporting capabilities.
“There is plenty of room for growth in this market, said VanWagenen. “Even with a steady increase in adoption over the past two years, KLAS estimates that only 20 to 25 percent of hospitals currently have a real-time infection surveillance system, which is up from 10 to 15 percent in 2009, but still significantly low overall.”
For more information or to purchase the report, click here.